Slide number 1
FTI Consulting’s study found that improving bronchoscopy sensitivity by 10% could increase economic value by $8,729 per patient, reducing lung cancer diagnosis time and improving patient outcomes.
Value Quantified
Measuring the Economic Impact of Diagnostic Testing
Value Quantified
Measuring the Economic Impact of Diagnostic Testing
Key Contact
How do you show that increased health screening isn’t just good for patients, but also makes good economic sense?
FTI Consulting’s Center for Healthcare Economics and Policy performed diagnostics research that demonstrated how the right tests can save lives and reduce costs, quantifying the value of cutting-edge diagnostic technologies and influencing key decisions in healthcare pricing and policy.
Our Impact
Our experts delivered peer-reviewed research papers and conference presentations in which better diagnostics and screening were shown to deliver major value: improving health outcomes while saving hundreds to thousands per patient.
Slide for Generating alt texts...
Our study demonstrated that testing symptomatic patients for COVID-19 and influenza with molecular point of care (“mPOC”) may be cost-saving compared to central lab PCR testing. The estimated per-patient savings were €263 in Germany, £74 in the UK and €65 in France in the home treatment scenario.
Slide for Generating alt texts...
The study showed that there is significant value in increasing lung cancer screening rates derived from reducing health disparities. Increasing lung cancer screening to 100% compliance was cost-effective ($64,654 per quality-adjusted life-year) and produced economic value by up to $560 per person. Up to 32.2% of the value was due to reductions in health disparities.
By the Numbers
The Case for Optimizing Screening
$8 729
Economic Value Per Patient
Improving bronchoscopy sensitivity by 10% could increase economic value by $8,729 per patient.
$64 654
Per Quality-Adjusted Year
Increasing lung cancer screening to 100% compliance was shown to be cost effective: $64,654 per quality-adjusted life-year.
$560
Economic Value Per Person
Increasing lung cancer screening to 100% compliance produced economic value of up to $560 per person.
In crisis and transformation,real-world experience delivers.
Our Role
Researching the economics of better healthcare
FTI Consulting conducted sophisticated modelling to quantify the value of new diagnostic technologies.
FTI Consulting partnered with key opinion leader (“KOL”) physicians to validate the results of the economic studies.
We developed peer-reviewed quality research papers and conference presentations to influence key stakeholders.
Related Experts
Discover Your Team
Real-world experience that delivers.
See why FTI Consulting is the leading global expert firm for organizations facing crisis and transformation.
More Success Stories
Deep Expertise in Action
See how our expert-driven, industry-focused approach produces real results in an increasingly complex world.
